Characteristics, Thrombus Resolution, and Long-Term Outcomes in Patients with Nonvalvular Atrial Fibrillation and Atrial Thrombus
- PMID: 37079758
- PMCID: PMC10126607
- DOI: 10.1177/10760296231168097
Characteristics, Thrombus Resolution, and Long-Term Outcomes in Patients with Nonvalvular Atrial Fibrillation and Atrial Thrombus
Abstract
To assess the prevalence and management of atrial thrombus in patients with nonvalvular atrial fibrillation (NVAF) and identify the risk factors of the nonresolution of atrial thrombus. This single-center retrospective observational study consecutively enrolled patients with NVAF and atrial thrombus detected using transesophageal echocardiography (TEE) or cardiac computed tomography angiography (CTA) from January 2012 to December 2020. Patients with prior left atrial appendage (LAA) intervention were excluded. The primary endpoint was the presence of atrial thrombus, while the secondary endpoint was the complete resolution of atrial thrombus. The prevalence of atrial thrombus in patients with NVAF was 1.4%. Ninety patients with atrial thrombus (mean age 62.8 ± 11.9 years and 61.1% men) were finally analyzed. Atrial thrombus was in the LAA in 82 (91.1%) patients. During follow up, 60% of the patients showed complete resolution of atrial thrombus. Congestive heart failure (odds ratio [OR]: 8.94; 95% confidence interval [CI]: 1.67-47.80) and a history of ischemic stroke (OR: 8.28; 95% CI: 1.48-46.42) were independently associated with the risk of the nonresolution of atrial thrombus. The presence of atrial thrombus in patients with NVAF who received anticoagulation therapy is non-negligible. Even in anticoagulated patients, TEE or cardiac CTA might still be needed. Congestive heart failure and a history of ischemic stroke are risk factors of the nonresolution of atrial thrombus.
Keywords: atrial fibrillation; atrial thrombus; non-vitamin K antagonist oral anticoagulants; resolution; warfarin.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures





Similar articles
-
Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.Pacing Clin Electrophysiol. 2019 Sep;42(9):1183-1190. doi: 10.1111/pace.13765. Epub 2019 Aug 6. Pacing Clin Electrophysiol. 2019. PMID: 31355470
-
Direct oral anticoagulants versus warfarin for the management of left atrial appendage thrombus in patients with acute stroke.J Neurol Sci. 2025 Jun 15;473:123516. doi: 10.1016/j.jns.2025.123516. Epub 2025 Apr 23. J Neurol Sci. 2025. PMID: 40300361
-
[Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Aug 24;46(8):606-610. doi: 10.3760/cma.j.issn.0253-3758.2018.08.006. Zhonghua Xin Xue Guan Bing Za Zhi. 2018. PMID: 30139010 Chinese.
-
Atrial Fibrillation in Heart Failure: Left Atrial Appendage Management.Cardiol Clin. 2019 May;37(2):241-249. doi: 10.1016/j.ccl.2019.01.009. Epub 2019 Feb 13. Cardiol Clin. 2019. PMID: 30926025 Review.
-
Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.J Am Coll Cardiol. 2021 Jun 15;77(23):2875-2886. doi: 10.1016/j.jacc.2021.04.036. J Am Coll Cardiol. 2021. PMID: 34112315
Cited by
-
Incidence and predictors of left atrial thrombus in patients with atrial fibrillation under anticoagulation therapy.Clin Res Cardiol. 2024 Aug;113(8):1242-1250. doi: 10.1007/s00392-024-02422-5. Epub 2024 Mar 6. Clin Res Cardiol. 2024. PMID: 38446148
-
Heart Failure and the Non-Resolution of Atrial Thrombus Detected in Anticoagulated Patients with Non-Valvular Atrial Fibrillation.Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251324922. doi: 10.1177/10760296251324922. Epub 2025 Mar 18. Clin Appl Thromb Hemost. 2025. PMID: 40101245 Free PMC article.
-
Influencing factors and predictive model for left atrial appendage emptying velocity in nonvalvular AF patients.Front Cardiovasc Med. 2024 Sep 19;11:1468379. doi: 10.3389/fcvm.2024.1468379. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39364064 Free PMC article.
References
-
- Di Minno MN, Ambrosino P, Dello Russo A, Casella M, Tremoli E, Tondo C. Prevalence of left atrial thrombus in patients with non-valvular atrial fibrillation. A systematic review and meta-analysis of the literature. Thromb Haemost. 2016;115(3):663‐677. - PubMed
-
- Andrade JG, Aguilar M, Atzema C, et al.The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36(12):1847‐1948. - PubMed
-
- Hindricks G, Potpara T, Dagres N, et al.2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373‐498. - PubMed
-
- January CT, Wann LS, Calkins H, et al.2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125‐e151. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical